EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly
GENEVA, May 25, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading global medical device company, participated in the Geneva Health Forum (GHF) 2025 Satellite Symposium, held as a side event of the World Health Assembly (WHA). Titled "China's Medical Technology Innovation and Its Implementation for Global Health," the event took place on May 20 in Geneva and was co-organized by Tsinghua University and the Université de Genève. It brought together innovators, policymakers, and development partners to explore how Chinese medical technology is advancing equitable healthcare, particularly in low- and middle-income countries (LMICs).
Representing EDAN, Co-Founder Mr. Xicheng Xie delivered a keynote sharing the company's experience in delivering accessible innovation to underserved communities. "Real innovation isn't just about cutting-edge technology — it's about bringing the right solutions to the people who need them the most," said Mr. Xie, reflecting on the company's three-decade journey and the evolving meaning of innovation.
In that spirit, Mr. Xie highlighted EDAN's efforts to develop medical technologies that are accessible, practical, and impactful in real-world settings. He shared detailed of an ongoing initiative using EDAN's Nano Series handheld diagnostic ultrasound system to support basic prenatal care in resource-limited environments. The project focuses on equipping primary healthcare workers with tools for early screening and timely referral for at-risk pregnancies. He also noted other impactful technologies, including palm-sized fetal dopplers, EDAN's IQ intelligent algorithm, and its smart ECG web platform — each designed to bridge infrastructure gaps and reduce reliance on scarce medical personnel.
With a long-standing presence across both high-end and resource-limited markets, EDAN has built a truly global footprint – from Europe to Africa. To strengthen local engagement and ensure more responsive service, it has established 22 subsidiaries worldwide. This localized support, combined with a commitment to frontline feedback, drives continuous product improvement and meaningful impact.
EDAN is also actively involved in a range of meaningful projects across LMICs, working alongside NGOs, public health agencies, and development partners. These include maternal health and women's care initiatives in South Africa, portable diagnostic deployments in West Africa, and ultrasound screening programs in Latin America. Each year, nearly 1,000 ultrasound devices are deployed globally through NGO-led programs. These partnerships not only expand access to essential care but also help build local capacity through training and support.
"At EDAN, we believe in bringing innovation and value together to improve the human condition," Xie concluded. "That mission is at the core of everything we do — from product design to global partnerships."
As EDAN celebrates its 30th anniversary in 2025, the company remains steadfast in its mission to deliver innovation that matters — especially for those who need it most.
About Edan Instruments, Inc.EDAN is dedicated to improving the human condition around the world by delivering value-driven, innovative, and high-quality medical products and services, pioneering a comprehensive line of medical solutions that address a broad range of healthcare practices including Patient Monitoring, Diagnostic ECG, OB/GYN, Ultrasound Imaging, Point-of-Care Testing, In-Vitro Diagnostics, and Animal Care.
View original content to download multimedia:https://www.prnewswire.com/news-releases/edan-highlights-commitment-to-global-health-at-ghf-2025-satellite-symposium-a-side-event-of-the-world-health-assembly-302464849.html
SOURCE EDAN Instruments, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Britain to allocate $116 billion to R&D in spending plan
LONDON (Reuters) -British finance minister Rachel Reeves will allocate 86 billion pounds ($116 billion) in this week's spending review to fund research and development, the Department for Science, Innovation and Technology (DSIT) said on Sunday. It said the package, funding everything from new drug treatments and longer-lasting batteries to artificial intelligence breakthroughs, would be worth over 22.5 billion pounds a year by 2029/30, driving new jobs and economic growth. Reeves will divide more than 2 trillion pounds ($2.7 trillion) of public money between her ministerial colleagues on Wednesday, making choices that will define what the year-old Labour government can achieve in the next four years. The DSIT said the announcement on R&D follows Reeves' commitment last week to 15.6 billion pounds of government investment in local transport in city regions in the Northern England, Midlands and the South West. ($1 = 0.7398 pounds)
Yahoo
3 hours ago
- Yahoo
China to fast-track applications for rare-earth minerals to US, EU
June 7 (UPI) -- China has agreed to fast-track approvals for the shipment of rare earth minerals to the United States and some European Union nations. U.S. President Donald Trump and Chinese leader Xi Jinping spoke Thursday about easing trade tensions. On Saturday, China's Minister Seceary Wang Wentao said his nation is "willing to establish a green channel for qualified applications to speed up approval." Details weren't given, including the speed of the process and which EU nations are included. China controls 90% of the global processing of rare earth minerals. Major deposits also are found in the United States, Australia and Russia. Smaller amounts are in Canada, India, South Africa and Southeast Asia. Rare earth minerals are in the Earth's crust, making them difficult to extract. They include lanthanide, scandium and yttrium, all on the Periodic Table of Elements. Some major minerals that contain rare earth elements are bastnasite, monazite, loparite and laterite clays. The first rare-earth mineral was discovered in 1787 -- gadolinite, a black mineral composed of cerium, yttrium, iron, silicon and other elements. U.S. needs rare earth minerals The minerals are critical to American industries and defense, including use in cars and fighter jets. Batteries contain the minerals Trump posted on Truth Social on Thursday "there should no longer be any questions respecting the complexity of rare Earth products." On April 29, the United States and Ukraine created a Reconstruction Investment Fund that includes rare earth mineral rights in the European nation. Trump and Ukrainian President Volodymyr Zelensky were originally set to sign the minerals deal on Feb. 28, but the plan was scrapped after a tense exchange between them in the Oval Office in which Trump accused him of "gambling with World War III." The United States wants access to more than 20 raw materials in Ukraine, including some non-minerals, such as oil and natural gas, as well as titanium, lithium, graphite and manganese. The Chinese commerce ministry confirmed some applications have been approved without specifying industries covered. Some Chinese suppliers have recently received six-month export licenses, the American Chamber of Commerce in China said Friday, but it noted that there is a backlog of license applications. In a survey of member companies conducted by the American Chamber of Commerce in China late week, 75% say their stock would run out within three months, CNN reported. Jens Eskelund, the chamber president, said member companies were "still struggling" with the situation. "I hadn't realized just how important this rare earth card was before. Now the U.S. side is clearly anxious and eager to resolve this issue," he said a video on Thursday. "But of course, we'll link this issue to others -- the U.S. is restricting China on chips and jet engines, then China certainly has every reason to make use of this card. "As for whether China will change its rare earth export control policy, that probably still needs to be negotiated in more detail," Jin added. Trump said Xi and himself "straightened out" some points related to rare earth magnets, calling it "very complex stuff." The U.S. federal government said China had reneged on its promise made in Geneva on May 12. Delegations from Beijing and Washington plan to meet in Great Britain on Monday for trade negotiations. At the height of tariff war, China had imposed export restrictions on some minerals on April 4. Trump two days planned a 120% "reciprocal" tax on top of 25% levy on Chinese goods. But one week later it paused the bigger tariffs, including on other countries for 90 days. European nations' needs China's commerce ministry pledged to address the EU's concerns and establish a "green channel" for eligible applications to expedite approvals. He went to Brussels, Belgium, earlier this week and met with European Union's trade commissioner, Maros Sefcovic. It's a problem for China and the EU. Sefcovic said the pause was slowing deliveries for manufacturers of a wide range of items from cars to washing machines. Wang urged the EU to "take effective measures to facilitate, safeguard and promote compliant trade of high-tech products to China." On Friday, the European Chamber, a Beijing lobby group, warned progress had "not been sufficient" to prevent severe supply chain disruptions for many companies.
Yahoo
3 hours ago
- Yahoo
No more leprechaun economics: Ireland's tax swindle is finally ending
Donald Trump has sent Ireland to the naughty step. Once the altar boy of American commerce, Dublin now finds itself blacklisted alongside China, Germany and Vietnam, each a prime candidate for tariffs and sanctions. The offence? Running a surplus with the United States. On the face of it, the complaint seems petty. One country sells more than it buys. So what? But Ireland's problem, like the others on Trump's list, is that its surplus rests on a creed that has fallen out of favour. As offshoring hollowed out Middle America, the old Clinton mantra 'It's the economy, stupid' has begun to sound rather less clever than it once did. That, at least, is the mood in Trump's Washington. And judging by his campaign-trail fixation with the word tariff, many Americans agree: a reckoning is overdue. Ireland offers a particularly inviting target. Its surplus owes less to tangible exports than to tax gymnastics. A pill is made in Ireland for 50 cents, sold to a sister company (also in Ireland) for €10, and then shipped to the global market at the same price. The profit is booked in Dublin, while tax collectors elsewhere are left out of pocket. The trick doesn't stop there. Intellectual property is shifted to Irish subsidiaries, global sales are routed through Irish entities, and profits vanish into low or no-tax jurisdictions. Together, these sleights of hand form what we're invited to call the Irish economic miracle – a miracle that, by one estimate, deprives other countries of nearly $20 billion a year in tax revenue. The question being asked in Washington is: who benefits? Ireland, clearly. One in every eight euros of its tax revenue now comes from US firms. That's a fivefold increase since 2010, driven by Ireland's famously 'competitive' tax regime. It accounts for a large slice of a €150 billion bilateral surplus. When Irish Taoiseach Micheál Martin visited the Oval Office in March, Trump put it plainly: 'We do have a massive deficit with Ireland, because Ireland was very smart. They took our pharmaceutical companies away.' It's hard to argue with the logic. Ireland has been undeniably clever at attracting American capital. Spending it is another matter. Much of the money sits on Irish books without generating the economic activity one might expect. The state's coffers may be overflowing, but the windfall is narrowly concentrated. Public spending, as ever, has been handled with something shy of brilliance. From roads and hospitals to housing and energy, the services most visible to the public have seen little improvement, despite years of surging resources have been channelled into more headline-friendly ventures: a €350,000 bike shed outside parliament; a vast new hospital project already among Europe's most expensive; and billions annually to accommodate asylum applicants – most of whom, the government has conceded, are economic migrants. The miracle, it seems, left little room for prudence. As every lottery winner learns, easy money tends to breed excess. But with full coffers, Ireland could afford to paper over the cracks. Meanwhile, American tech and pharma giants have flourished. Apple, Microsoft, Pfizer and others have routed billions through Ireland, to the delight of shareholders and pension funds. If Trump moves to close loopholes or impose tariffs, these are the interests he'll have to console ahead of the midterms. The losers, predictably, are the American workers left behind by the long, slow flight of industry and tax revenue. Worse off still are the countries quietly drained by Ireland's magic act. The sums involved are vast. The structures that move them are so complex they can feel impossibly abstract. But the consequences are not. According to modelling by the Universities of St Andrews and Leicester, this tax loss has deprived more than 100,000 children of school attendance and some 1.1 million people of access to basic sanitation. Quibble with the methods if you like, but the core truth is hard to deny: when profits are rerouted, people are short-changed. Not that Dublin seems overly troubled. Only last month, Ireland's Taoiseach declared: 'Ireland earns its living from an open and fair approach to world trade.' The most pious nations often turn out to be the most artful. Ireland rarely misses a chance to sermonise on Gaza, climate justice, or whichever cause currently allows it to cast itself as Europe's moral compass. But as La Rochefoucauld noted, hypocrisy is the tribute vice pays to virtue. And by that measure, Ireland has paid handsomely. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
